XML 78 R5.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Balance Sheet - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Current Assets:    
Cash and cash equivalents $ 13 $ 7
Accounts receivable - trade (less allowance for doubtful accounts) 665 525
Unbilled revenue 415 346
Miscellaneous accounts receivable 107 96
Inventories 774 762
Current regulatory assets 387 366
Other current assets 210 162
Total current assets 2,571 2,264
Property, Plant, and Equipment, Net 39,313 36,304
Investments and Other Assets:    
Nuclear decommissioning trust fund 1,526 1,342
Goodwill 411 411
Regulatory Asset, Noncurrent 2,524 2,397
Pension and other postretirement benefits 977 757
Other assets 1,154 1,123
Total investments and other assets 6,592 6,030
TOTAL ASSETS 48,476 44,598
Current Liabilities:    
Long-Term Debt, Current Maturities 973 317
Short-term debt 643 1,143
Accounts and wages payable 1,254 1,059
Interest accrued 229 196
Customer deposits 238 223
Other current liabilities 570 475
Total current liabilities 3,907 3,413
Long-Term Debt, Excluding Current Maturities 18,214 17,262
Deferred Credits and Other Liabilities:    
Accumulated deferred income taxes and production and investment tax credits, net 5,181 4,474
Regulatory liabilities 6,255 5,897
Asset retirement obligations 849 822
Other deferred credits and liabilities 540 487
Total deferred credits and other liabilities 12,825 11,680
Commitments and Contingencies (Notes 2, 9, and 14)
Shareholders' Equity:    
Common stock 3 3
Other paid-in capital, principally premium on common stock 8,106 7,513
Retained earnings 5,292 4,604
Accumulated other comprehensive loss 0 (6)
Total shareholders' equity 13,401 12,114
Noncontrolling Interests 129 129
Total equity 13,530 12,243
TOTAL LIABILITIES AND EQUITY $ 48,476 $ 44,598